October 5, 2017 / 6:24 AM / in 18 days

BRIEF-BTG Plc reiterates full year product sales guidance

Oct 5 (Reuters) - BTG PLC:

* ‍GROUP REITERATES ITS PRODUCT SALES GUIDANCE FOR FULL YEAR

* ‍SPECIALTY PHARMACEUTICALS IS EXPECTED TO GROW BY LOW-TO-MID SINGLE DIGITS AT CER IN FY, WEIGHTED AS EXPECTED TO FIRST HALF.​

* ‍“DELIVERED A GOOD PERFORMANCE IN FIRST HALF OF YEAR, WITH DOUBLE-DIGIT CER 1 PRODUCT SALES GROWTH”​

* CONSIDERING OPTIONS, INCLUDING APPEALING RULING AND LEVEL OF DAMAGES AWARDED REGARDING LITIGATION WITH WELLSTAT THERAPEUTICS CORPORATION​ Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below